FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127858360> ?p ?o ?g. }

• W3127858360 endingPage "19" @default.
• W3127858360 startingPage "1" @default.
• W3127858360 abstract "Introduction: Acute kidney injury is a widespread complication in hospitalized patients, with a high mortality rate and long-term complications affecting prognosis and quality of life and with high human and financial costs. In addition, to date, no clear algorithm for the prevention of this type of damage has been developed.&#x0D; Materials and methods: The research was carried out on male Wistar rats. A 40-minute renal ischemia-reperfusion model was used to model acute kidney injury. Further, the renoprotective properties of carbamylated darbepoetin, udenafil and their combination were assessed based on the analysis of the biochemical studies’ results, dynamics of the renal status and the renal microvasculature, and the pathomorphological picture. A series of experiments was also carried out to assess the contribution of adenosine triphosphate-dependent potassium channels and nuclear factor kappa B to the renoprotective properties of the said agents.&#x0D; Results and discussion: Prophylactic administration of carbamylated darbepoetin at a dose of 50 μg/kg and udenafil at a dose of 8.7 mg/kg led to a statistically significant decrease in creatinine and blood urea nitrogen, an increase in glomerular filtration rate with a simultaneous decrease in fractional excretion of sodium, as well as an increase in the level of microcirculation in the kidneys and a decrease in the severity of damage according to the data of a pathomor­phological examination at all time points of the experiment. A higher efficiency of correcting ischemic and reperfusion renal injuries was observed when using a combination of the said pharmacological agents. A series of experiments with glibenclamide demonstrated that its preliminary administration levels the renoprotective properties of carbamylated darbepoetin and udenafil. The ability of the studied pharmacological agents to reduce lipopolysaccharide-induced ex­pression of nuclear factor kappa B in mononuclear cells was also demonstrated. The results of the research suggest that the renoprotective effects of carbamylated darbepoetin, udenafil, and their combination are realized through ATP-de­pendent potassium channels and nuclear factor kappa B.&#x0D; Conclusion: Pharmacological preconditioning with carbamylated darbepoetin and udenafil reduces the severity of acute kidney injury induced by ischemia-reperfusion." @default.
• W3127858360 created "2021-02-15" @default.
• W3127858360 creator A5058057969 @default.
• W3127858360 creator A5085553617 @default.
• W3127858360 creator A5090375131 @default.
• W3127858360 date "2021-01-28" @default.
• W3127858360 modified "2023-10-10" @default.
• W3127858360 title "Renoprotective effect of carbamylated darbepoetin and udenafil in ischemia-reperfusion of rat kidney due to the effect of preconditioning and inhibition of nuclear factor kappa B" @default.
• W3127858360 cites W1516311606 @default.
• W3127858360 cites W154036014 @default.
• W3127858360 cites W1732667972 @default.
• W3127858360 cites W1970067145 @default.
• W3127858360 cites W1971799714 @default.
• W3127858360 cites W2027666348 @default.
• W3127858360 cites W2029698635 @default.
• W3127858360 cites W2055300324 @default.
• W3127858360 cites W2058982742 @default.
• W3127858360 cites W2067889445 @default.
• W3127858360 cites W2091333494 @default.
• W3127858360 cites W2091631175 @default.
• W3127858360 cites W2107142117 @default.
• W3127858360 cites W2110788486 @default.
• W3127858360 cites W2119421595 @default.
• W3127858360 cites W2139300304 @default.
• W3127858360 cites W2161854192 @default.
• W3127858360 cites W2336644165 @default.
• W3127858360 cites W2521907742 @default.
• W3127858360 cites W2552768689 @default.
• W3127858360 cites W2576202064 @default.
• W3127858360 cites W2621553746 @default.
• W3127858360 cites W2624430479 @default.
• W3127858360 cites W2731659524 @default.
• W3127858360 cites W2739920288 @default.
• W3127858360 cites W2750514629 @default.
• W3127858360 cites W2765358245 @default.
• W3127858360 cites W2767787480 @default.
• W3127858360 cites W2775555460 @default.
• W3127858360 cites W2788835551 @default.
• W3127858360 cites W2886181111 @default.
• W3127858360 cites W2899256948 @default.
• W3127858360 cites W2917645219 @default.
• W3127858360 cites W2927159881 @default.
• W3127858360 cites W2940601661 @default.
• W3127858360 cites W2946990912 @default.
• W3127858360 cites W2951925526 @default.
• W3127858360 cites W2974257765 @default.
• W3127858360 cites W2998628417 @default.
• W3127858360 cites W3003250358 @default.
• W3127858360 cites W3006707029 @default.
• W3127858360 cites W3087672831 @default.
• W3127858360 doi "https://doi.org/10.3897/rrpharmacology.7.63059" @default.
• W3127858360 hasPublicationYear "2021" @default.
• W3127858360 type Work @default.
• W3127858360 sameAs 3127858360 @default.
• W3127858360 citedByCount "0" @default.
• W3127858360 crossrefType "journal-article" @default.
• W3127858360 hasAuthorship W3127858360A5058057969 @default.
• W3127858360 hasAuthorship W3127858360A5085553617 @default.
• W3127858360 hasAuthorship W3127858360A5090375131 @default.
• W3127858360 hasBestOaLocation W31278583601 @default.
• W3127858360 hasConcept C126322002 @default.
• W3127858360 hasConcept C126894567 @default.
• W3127858360 hasConcept C12722491 @default.
• W3127858360 hasConcept C159641895 @default.
• W3127858360 hasConcept C2778176769 @default.
• W3127858360 hasConcept C2780091579 @default.
• W3127858360 hasConcept C2780114680 @default.
• W3127858360 hasConcept C2780306776 @default.
• W3127858360 hasConcept C2780343553 @default.
• W3127858360 hasConcept C2780472472 @default.
• W3127858360 hasConcept C2780721119 @default.
• W3127858360 hasConcept C541997718 @default.
• W3127858360 hasConcept C71924100 @default.
• W3127858360 hasConcept C98274493 @default.
• W3127858360 hasConceptScore W3127858360C126322002 @default.
• W3127858360 hasConceptScore W3127858360C126894567 @default.
• W3127858360 hasConceptScore W3127858360C12722491 @default.
• W3127858360 hasConceptScore W3127858360C159641895 @default.
• W3127858360 hasConceptScore W3127858360C2778176769 @default.
• W3127858360 hasConceptScore W3127858360C2780091579 @default.
• W3127858360 hasConceptScore W3127858360C2780114680 @default.
• W3127858360 hasConceptScore W3127858360C2780306776 @default.
• W3127858360 hasConceptScore W3127858360C2780343553 @default.
• W3127858360 hasConceptScore W3127858360C2780472472 @default.
• W3127858360 hasConceptScore W3127858360C2780721119 @default.
• W3127858360 hasConceptScore W3127858360C541997718 @default.
• W3127858360 hasConceptScore W3127858360C71924100 @default.
• W3127858360 hasConceptScore W3127858360C98274493 @default.
• W3127858360 hasIssue "1" @default.
• W3127858360 hasLocation W31278583601 @default.
• W3127858360 hasLocation W31278583602 @default.
• W3127858360 hasLocation W31278583603 @default.
• W3127858360 hasLocation W31278583604 @default.
• W3127858360 hasOpenAccess W3127858360 @default.
• W3127858360 hasPrimaryLocation W31278583601 @default.
• W3127858360 hasRelatedWork W2062717800 @default.
• W3127858360 hasRelatedWork W2076649548 @default.
• W3127858360 hasRelatedWork W2127896754 @default.

• next